United Therapeutics (UTHR) Tops Q2 EPS by 82c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $495.10 -1.23%
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Net income per diluted common share (in dollars per share): 3.5
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q2 EPS of $3.98, $0.82 better than the analyst estimate of $3.16. Revenue for the quarter came in at $444.5 million versus the consensus estimate of $368.58 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
- HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
- UBS Reiterates Buy Rating on NVIDIA (NVDA), Expects Q2 Revenue Beat
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
